Olympus America Licenses Patents to BioImagene

BioImagene Inc. and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement that allows BioImagene to access Olympus’ patent portfolio in the field of digital pathology and virtual microscopy.

The license is the most recent that Olympus has granted for the technologies, which are critical for developing future digital imaging and data handling systems for pathology.

Digital pathology technologies offer the potential to change the way doctors review and manage biopsy slides and other pathology specimens handled using glass slides and traditional optical microscopes. The patents included in the deal will cover methods and equipment for creating, storing and delivering virtual microscopy slides.

The technology will enable pathologists to view and share high-resolution virtual microscopy images via the Internet.

No specific terms or conditions were made public.

Located in Sunnyvale, Calif., BioImagene provides scalable digital pathology solutions for diagnostics.

For more information, visit: www.olympusamerica.com